P. Saunders (London, United Kingdom), D. Lacedonia (Molfetta (BA), Italy)
Hypersentivity pneumonitis in an Interstitial Lung Disease Unit, 5 years’ experience
A. Urrutia Gajate (Bilbao (Bizkaia), Spain), A. Rezola Carasusan (Bilbao (Bizkaia), Spain), B. Ortiz De Urbina (Bilbao (Bizkaia), Spain), M. Garcia Moyano (Bilbao (Bizkaia), Spain), R. Zalacain Jorge (Bilbao (Bizkaia), Spain), L. Ruiz Iturriaga (Bilbao (Bizkaia), Spain), L. Serrano Fernandez (Bilbao (Bizkaia), Spain), C. Jaca Michelena (Bilbao (Bizkaia), Spain), B. Gomez Crespo (Bilbao (Bizkaia), Spain)
|   |
Chest Imaging Abnormalities in Patients with Uncontrolled Rheumatoid Arthritis Prior to Biological Therapy Initiation
A. Benjamin (London, United Kingdom), K. Ward (London, United Kingdom)
| |
Clinico-radiological profile of connective tissue diseases related interstitial lung diseases
M. Agarwal (Jodhpur, India), M. Gupta (Jaipur, India), N. Bharti (Jodhpur, India), G. Chawla (Jodhpur, India)
| |
Use of mycophenolate mofetil for the treatment of hypersensitivity pneumonitis>
E. Velez Segovia (Barcelona, Spain), X. Vidal Guitart (Barcelona, Spain), A. Villar Gomez (Barcelona, Spain)
| |
The prediction of risk factors of tyrosine kinase inhibitor-induced pneumonitis in non-small cell lung cancer
H. Kang (Goyang, Republic of Korea)
| |
CARACTERISTICS OF A PROSPECTIVE COHORT OF PATIENTS WITH IPAF (INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES) BY NEUMOLOGISTS AND REUMATOLOGISTS OF MADRID. IPAF-NEREM STUDY
M. Nieto Barbero (Madrid, Spain), C. Vadillo Font (Madrid, Spain), M. Rodríguez-Nieto (Madrid, Spain), O. Sánchez Pernaute (Madrid, Spain), F. Romero Bueno (Madrid, Spain), R. Laporta Hernández (Madrid, Spain), B. López Muñiz Ballesteros (Madrid, Spain), L. Cebrián Martínez (Madrid, Spain), M. Río Martínez (Madrid, Spain), G. Mora Ortega (Madrid, Spain), T. Cobo Ibánez (Madrid, Spain), L. Abásolo Alcazar (Madrid, Spain)
| |
Relationship between horizontal adductor muscles strength and pulmonary functions in idiopathic pulmonary fibrosis
H. Durdu (Giresun, Turkey), S. Yurdalan (Istanbul, Turkey), I. Özmen (Istanbul, Turkey)
| |
Telemetric observation of the course and treatment effects of selected interstitial lung diseases associated with connective tissue diseases (CTD-ILD) – protocol presentation
M. Mozga (Lódz, Poland), S. Malysiak-Szponder (Lódz, Poland), J. Milkowska - Dymanowska (Lódz, Poland), A. Bialas (Lódz, Poland), W. Piotrowski (Lódz, Poland)
| |
King’s Brief Interstitial Lung Disease (K-BILD) questionnaire: content relevance in progressive fibrosing ILD (PF-ILD)
S. Birring (London, United Kingdom), D. Bushnell (Bethesda, MD, United States of America), K. Cutts (Bethesda, MD, United States of America), M. Baldwin (Ingelheim am Rhein, Germany), K. Rohr (Ingelheim am Rhein, Germany), N. Male (Ingelheim am Rhein, Germany)
| |
Utility of Lung Ultrasound in Interstitial Lung Disease - A Paradigm Shift
G. Chawla (Jodhpur, India), N. Dutt (Jodhpur, India), N. Chauhan (Jodhpur, India), R. Niwas (Jodhpur, India), S. Agarwal (New Delhi, India), P. Jain (Jodhpur, India), M. Agarwal (Jodhpur, India)
| |
Impact of mycophenolate mofetil on lung function in chronic hypersensitivity pneumonitis and connective tissue disease related-ILD
E. Soares Seixas (Aveiro, Portugal), P. Serra (Aveiro, Portugal), R. Aguiar (Aveiro, Portugal), M. Ferreira (Aveiro, Portugal), P. Ferreira (Aveiro, Portugal)
| |
Exploring barriers to Pirfenidone adherence in patients with idiopathic pulmonary fibrosis: a prospective study
A. Delameillieure (Leuven, Belgium), F. Dobbels (Leuven, Belgium), K. Leceuvre (Leuven, Belgium), D. Strens (Leuven, Belgium), P. Simaels (Leuven, Belgium), K. Verheyen (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), W. Wuyts (Leuven, Belgium)
| |
Use of Rituximab in the treatment of CTD-ILD in RA patients.
F. Bini (Milano (Mi), Italy), D. Visca (Tradate (Va), Italy), A. De Lauretis (Milano (Mi), Italy), B. Bodini (Milano (Mi), Italy), D. Colombo (Milano (Mi), Italy), P. Faverio (Monza, Italy), A. Vaghi (Monza, Italy)
| |
Title : Video Assisted Thoracoscopy Surgery(VATS) in unidentified Interstitial Lung disease: a six year retrospective study in India
A. Agarwal (Delhi, India), A. Lall (Delhi, India)
| |
Risk factors of transbronchial cryobiopsy complications: A Retrospective Study of 500 Patients
K. Higa (Yokohama, Japan), T. Niwa (Yokohama, Japan), M. Sato (Yokohama, Japan), Y. Sato (Yokohama, Japan), A. Sekine (Yokohama, Japan), H. Kitamura (Yokohama, Japan), T. Baba (Yokohama, Japan), T. Iwasawa (Yokohama, Japan), T. Takemura (Yokohama, Japan), T. Ogura (Yokohama, Japan)
| |